CHICAGO, July 28, 2022 (GLOBE NEWSWIRE) -- We are advised that journalists and other readers should disregard the news release, “Petros Pharmaceuticals to be Acquired by Henry Crown and Company for $3.25 per share” issued July 28, 2022, over GlobeNewswire.
![Henry-Crown-and-Company.png](https://ml.globenewswire.com/media/YTU1MGE5MjQtOGRhMS00OGJkLWI2MDQtZGM3ZWViMzEyZmNiLTEyNjIyODk=/tiny/Henry-Crown-and-Company.png)